Compound class:
Synthetic organic
Comment: EAI045 is an allosteric inhibitor of mutant forms of the EGFR found in lung cancers whilst sparing the wild-type receptor [1]. Allosteric inhibitors are being developed to overcome acquired resistance to current EGFR tyrosine kinase inhibitors which bind to the ATP pocket of the enzyme, which is the location of the many identified resistance mutations.
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
2-(5-fluoro-2-hydroxyphenyl)-2-(1-oxo-2,3-dihydro-1H-isoindol-2-yl)-N-(1,3-thiazol-2-yl)acetamide |
Database Links | |
GtoPdb PubChem SID | 315661298 |
PubChem CID | 121231412 |
Search Google for chemical match using the InChIKey | YTUFHOKUFOQRDF-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | YTUFHOKUFOQRDF |
UniChem Compound Search for chemical match using the InChIKey | YTUFHOKUFOQRDF-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | YTUFHOKUFOQRDF-UHFFFAOYSA-N |